Jin10 data, April 6 - Shengda Bio announced that the company’s major shareholder, Tiantai Wanjian Investment Development Center (Limited Partnership), has implemented the previously disclosed share reduction plan, reducing its holdings by 2,328,400 shares through centralized bidding and Block Trading, accounting for approximately 1.36% of the company’s total share capital. This equity change does not trigger a mandatory acquisition and will not result in a change in the company’s controlling shareholder or actual controller.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Sangda Bio: Wanjian Investment reduces its stake by approximately 1.36%.
Jin10 data, April 6 - Shengda Bio announced that the company’s major shareholder, Tiantai Wanjian Investment Development Center (Limited Partnership), has implemented the previously disclosed share reduction plan, reducing its holdings by 2,328,400 shares through centralized bidding and Block Trading, accounting for approximately 1.36% of the company’s total share capital. This equity change does not trigger a mandatory acquisition and will not result in a change in the company’s controlling shareholder or actual controller.